4//SEC Filing
Romberger Timothy 4
Accession 0000899243-21-025826
CIK 0001662244other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 8:52 PM ET
Size
9.2 KB
Accession
0000899243-21-025826
Insider Transaction Report
Form 4
Romberger Timothy
Director
Transactions
- Conversion
Series B Convertible Preferred Stock
2021-06-22−200,000→ 0 total→ Common Stock (58,670 underlying) - Conversion
Series A Convertible Preferred Stock
2021-06-22−69,503→ 0 total→ Common Stock (20,390 underlying) - Conversion
Common Stock
2021-06-22+79,060→ 369,448 total
Footnotes (1)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date.
Documents
Issuer
Cyteir Therapeutics, Inc.
CIK 0001662244
Entity typeother
Related Parties
1- filerCIK 0001864900
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 8:52 PM ET
- Size
- 9.2 KB